Purchases and Sales Made in Q4 2024 in Adaptimmune Therapeutics PLC (ADAP)
This table provides information about the institutional ownership of Adaptimmune Therapeutics PLC (ADAP) during Q4 2024. The information is specifically focused on institutions that hold shares of Adaptimmune Therapeutics PLC.
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Feb 14, 2025
Q4 2024
|
Israel Englander
Millennium Management LLC | New York, Ny
|
SELL
|
- |
-686K- 95.87% |
$370K - $652K
|
29.6K
$7.98K
|
|
|
Feb 14, 2025
Q4 2024
|
Bank Of America Corp
Charlotte, NC |
SELL
|
- |
-1.79M- 38.49% |
$967K - $1.7M
|
2.86M
$773K
|
|
|
Jan 31, 2025
Q4 2024
|
Baillie Gifford & CO
|
SELL
|
- |
-4.96M- 29.55% |
$2.68M - $4.71M
|
11.8M
$3.19M
|
|
|
Feb 14, 2025
Q4 2024
|
Pfm Health Sciences, LP
San Francisco, CA |
SELL
|
- |
-5.13M- 51.28% |
$2.77M - $4.87M
|
4.87M
$1.32M
|